Skip to main content
OS-061 Multicenter, randomized, double-blind, placebo-controlled trial of Fatty Acid Synthase (FASN) inhibitor, denifanstat, versus placebo in the treatment of biopsy-proven NASH: A 26-week interim analysis of the FASCINATE-2 Phase 2B trial
Published Web Location
http://doi.org/10.1016/s0168-8278(23)00515-9No data is associated with this publication.